Skip to main content
. 2021 Jun 16;218(8):e20210040. doi: 10.1084/jem.20210040

Figure 5.

Figure 5.

In vivo validation of chemotaxis-inducing and inflammatory macrophages after SCI. (A) Immunohistochemical validation of chemotaxis-inducing and inflammatory macrophages and their temporal changes after SCI. Injured spinal cord tissue shows a steady increase in macrophages (CD11b+/CD63+) over time. APOE expression differentiates between chemotaxis-inducing (CD11b+/CD63+/APOElo) and inflammatory (CD11b+/CD63+/APOEhi) macrophages. Chemotaxis-inducing macrophages are identified by white arrowheads, while inflammatory macrophages are identified by red arrowheads. Boxed regions on the left are shown in higher magnification on the right. Representative images from a total of three biological replicates per each time point. Scale bars in merged images are 300 µm, and scale bars in magnified images are 25 µm. Blue is DAPI to label nuclei. (B) Scatter plot of flow cytometry analysis and gating strategy (see Materials and methods for description) to quantify relative proportions of the two macrophage subtypes. After excluding neutrophils and lymphocytes, monocytes/macrophages were separated from microglia based on CD11b and CD45. After gating for CD63hi macrophages, separation based on CD11b and APOE resulted in CD11bmed/APOElo (chemotaxis-inducing macrophages) and CD11bhi/APOEhi (inflammatory macrophages) clusters. (C) Quantification showed increased proportion of CD11bhi/APOEhi macrophages at 7 dpi compared with 1 dpi. n = 5 biological replicates at each time point for flow cytometry experiment. Macro, macrophage; Mono, monocyte.